TIGER Balm maker Haw Par Corp’s profit fell 5.5 per cent to S$106.3 million for the six months ended Dec 31, 2024, on the ...

However, the group said that it saw higher operating costs for the year due to cost of sales increasing, which resulted in gross profit margin dropping.

1 Day H02 0.54% DJIA 0.78% S&P Mid Cap 400 0.41% Health Care/Life Sciences 1527.34% ...

Key Insights Haw Par's significant private companies ownership suggests that the key decisions are influenced by... Key Insights Using the 2 Stage Free Cash Flow to Equity, Haw Par fair value ...

Haw Par, the maker of Tiger Balm, saw its profit soar by 46% YoY to $216.6m in FY23. In a bourse filing, the company attributed its higher profit to improved healthcare revenue, which saw a 30.1% ...

a wholly-owned subsidiary of Singapore's Haw Par Healthcare, to exclusively market and distribute Tiger Balm range of products in the country," Alkem Labs said in a regulatory filing. Advisory ...